Both controls and cases in the trial had an approximate mortality rate of 15% at day 90.
Antibody combo Evusheld did not improve COVID outcomes in small trial
Published in COVID-19
More from COVID-19More posts in COVID-19 »
November 27, 2024
The International Organization for the Proctection Against COVID-19
Both controls and cases in the trial had an approximate mortality rate of 15% at day 90.
Published in COVID-19